Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-10

FDA Approved: BICALUTAMIDE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare Inc.'s supplemental application for bicalutamide, authorizing changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bicalutamide (bicalutamide)

Snippet

SUPPL AP for BICALUTAMIDE (BICALUTAMIDE)